Zynex (NASDAQ:ZYXI) Rating Lowered to “Neutral” at LADENBURG THALM/SH SH
LADENBURG THALM/SH SH lowered shares of Zynex (NASDAQ:ZYXI – Free Report) from a buy rating to a neutral rating in a report released on Wednesday morning, MarketBeat.com reports. Separately, HC ...
Zynex (NASDAQ:ZYXI) Downgraded to Sector Perform Rating by Royal Bank of Canada
Royal Bank of Canada cut shares of Zynex (NASDAQ:ZYXI – Free Report) from an outperform rating to a sector perform rating in a research report sent to investors on Wednesday, Marketbeat.com reports.
Zynex's Sell-Off Creates A Speculative Buying Opportunity
Zynex specializes in non-invasive pain management and patient monitoring, with promising advancements. Read why I think ZYXI ...
Zynex, Inc. Just Missed EPS By 55%: Here's What Analysts Think Will Happen Next
Zynex, Inc. ( NASDAQ:ZYXI ) just released its latest full-year report and things are not looking great. It wasn't ...
Zynex, Inc. (NASDAQ:ZYXI) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Good afternoon, ladies and gentlemen, and welcome to the Zynex ...
Zynex to Cut 15% of Workforce After Tricare Suspends Payments
Zynex is cutting 15% of its workforce after health insurance company Tricare temporarily suspended payments. The medical device maker said Tuesday it plans to cut jobs because Tricare has suspended ...
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation IntoZynex, Inc. (ZYXI)
Zynex develops, manufactures, markets and sells medical devices used for nerve stimulation, pain management, and rehabilitation, as well as non-invasive fluid, sepsis, and laser-based pulse oximetry ...
Zynex downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital downgraded Zynex (ZYXI) to Sector Perform from Outperform with a price target of $5.50, down from $11. The firm says the company’s ...
Fintel on MSN2d
Ladenburg Thalmann Downgrades Zynex (ZYXI)
Fintel reports that on March 12, 2025, Ladenburg Thalmann downgraded their outlook for Zynex (NasdaqGS:ZYXI) from Buy to ...
Zynex Shares Fall After Tricare Suspends Payments
Shares of Zynex fell after the it said that the health insurance company Tricare--which accounts for as much as 25% of its total revenue--has temporarily suspended payments as it reviews prior claims.
Q4 2024 Zynex Inc Earnings Call
Good afternoon, ladies and gentlemen, and welcome to the Zynex fourth-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like ...
Seeking Alpha3d
Zynex, Inc. (ZYXI) Q4 2024 Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Zynex Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in listen-only mode. A question-and-answer session ...